Practice &Training

Substance Use Criteria for HCV Treatment in Medicaid

​​Joshua M. Liao, Lee A. Fleisher & Amol S. Navathe | JAMA
Social comparisons are increasingly used to influence physicians' behavior. However, instead of simply ranking doctors against each other, professional "norms" are needed to ensure comparisons are appropriate.​ READ MORE​

​​Joshua M. Liao & Michael A. Fischer | American Journal of Public Health

Facing constrained budgets, most state Medicaid programs adopted prior authorization criteria for sofosbuvir, an expensive but effective treatment for hepatitis C. Despite the potential cost savings associated with strict behavioral criteria, they raise troubling questions in terms of public health as well as medical ethics, clinical evidence, and potentially federal law. READ MORE 

data & Narratives in pursuit of better health and Health care


Source: JAMA IM. 2016

Featured analysis

Cost & Quality of orthopedic joint replacement bundles

Evidence Based Medicine

Source:  AJPH. 2017. 

Provider Behavior

Featured analysis

Prescription Drug policy


Amol S Navathe, Andrea B. Troxel, Joshua M. Liao, et al | JAMA Internal Medicine

Medicare has accelerated its commitment to orthopedic bundled payment, but hospitals need guidance on how to succeed under new programs. We describe how bundled payment at one institution was associated with hospital savings and reduced Medicare payments. READ MORE